Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Koltrap 0.125mg Tablet

Prescription Icon
Prescription Required

Marketer

Pax Healthcare

Salt Composition

Methylergometrine (0.125mg)

Overview Koltrap 0.125mg Tablet

Uterine bleeding following childbirth or termination of pregnancy may be managed with Hemostop 0.125mg tablets. This medication acts on uterine smooth muscle, enhancing contractile strength, frequency, and intensity to minimize blood loss. Hemostop 0.125mg tablets can be ingested with or without food, but consistent timing maximizes efficacy. Dosage and frequency are determined by your physician based on individual needs and should be followed precisely. The prescribed duration of treatment should be completed. Swallow tablets whole with water. Common side effects include headache, elevated blood pressure, and convulsions. Report any concerning or severe side effects to your doctor; mitigation strategies may be available. Alcohol consumption is generally discouraged during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, and provide a complete list of all current medications, as interactions may reduce Hemostop's effectiveness or alter its action.

Uses of Koltrap 0.125mg Tablet

Hemorrhage postpartum

Major Benefits of Koltrap 0.125mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Koltrap 0.125mg Tablet whole; do not crush, chew, or divide it. This medication can be administered with or without food, however, consistent timing is recommended.

Common Side effects of Koltrap 0.125mg Tablet:

  • High blood pressure
  • Headache
  • Seizure

How to use Koltrap 0.125mg Tablet:

Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Koltrap 0.125mg Tablets can be consumed with or without food, although consistent timing is recommended.

How Koltrap 0.125mg Tablet works:

Ergotamine-based Koltrap 0.125mg tablets induce prolonged uterine smooth muscle constriction. This vascular compression effectively manages postpartum hemorrhage.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Koltrap 0.125mg Tablets may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Using Koltrap 0.125mg tablets during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and pregnant humans reveals substantial risks to fetal development.

Breast feedingBreast feedingCAUTION

Use of Koltrap 0.125mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while taking Koltrap 0.125mg Tablets is undetermined. Refrain from driving should you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data on Koltrap 0.125mg Tablet use in individuals with impaired renal function is scarce. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Koltrap 0.125mg tablets to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Koltrap 0.125mg Tablet :

Should you forget a Koltrap 0.125mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Koltrap 0.125mg Tablet

LabelValue
Chemical Category Ergoline alkaloids
Developing Good Habits No.
Treatment Category Obstetrics and Gynecology
Actions Drugs inducing uterine contractions and abortion

FAQs on Koltrap 0.125mg Tablet

As directed by your doctor, take one 0.125mg Koltrap tablet orally three to four times daily for up to a week post-delivery. Dosage depends on your condition and response; always follow your doctor's instructions.
Individuals with hypertension, heart, liver, or kidney disease, a history of seizures, or who are pregnant should not use Koltrap 0.125mg tablets. Uterine contractions are a potential risk in pregnancy.
Koltrap 0.125mg tablets can transfer to breast milk, potentially harming a nursing baby. Breastfeeding should be delayed for at least 12 hours after taking a Koltrap 0.125mg tablet.
Koltrap 0.125mg Tablets may cause hypertension and seizures, both serious side effects. Seek immediate medical attention if this occurs.
Patients with coronary artery disease risk factors (such as smoking, obesity, diabetes, or high cholesterol) may experience an increased risk of heart blockage and serious complications when taking Koltrap 0.125mg tablets.
Koltrap 0.125mg Tablet
78
MRP 90
13% off